Back to Search
Start Over
Cholesterol and Morpholine Grafted Cationic Amphiphilic Copolymers for miRNA-34a Delivery
- Source :
- Molecular Pharmaceutics. 15:2391-2402
- Publication Year :
- 2018
- Publisher :
- American Chemical Society (ACS), 2018.
-
Abstract
- miR-34a is a master tumor suppressor playing a key role in the several signaling mechanisms involved in cancer. However, its delivery to the cancer cells is the bottleneck in its clinical translation. Herein we report cationic amphiphilic copolymers grafted with cholesterol (chol), N, N-dimethyldipropylenetriamine (cation chain) and 4-(2-aminoethyl)morpholine (morph) for miR-34a delivery. The copolymer interacts with miR-34a at low N/P ratios (∼2/1) to form nanoplexes of size ∼108 nm and a zeta potential ∼ +39 mV. In vitro studies in 4T1 and MCF-7 cells indicated efficient transfection efficiency. The intracellular colocalization suggested that the copolymer effectively transported the FAM labeled siRNA into the cytoplasm within 2 h and escaped from the endo-/lysosomal environment. The developed miR-34a nanoplexes inhibited the breast cancer cell growth as confirmed by MTT assay wherein 28% and 34% cancer cell viability was observed in 4T1 and MCF-7 cells, respectively. Further, miR-34a nanoplexes possess immense potential to induce apoptosis in both cell lines.
- Subjects :
- 0301 basic medicine
Cell Survival
Polymers
Morpholines
Pharmaceutical Science
Apoptosis
Breast Neoplasms
02 engineering and technology
Transfection
Mice
03 medical and health sciences
chemistry.chemical_compound
Cell Line, Tumor
Morpholine
Drug Discovery
Animals
Humans
MTT assay
Drug Carriers
Cationic polymerization
Genetic Therapy
021001 nanoscience & nanotechnology
In vitro
Gene Expression Regulation, Neoplastic
MicroRNAs
Cholesterol
030104 developmental biology
chemistry
Cytoplasm
Cancer cell
MCF-7 Cells
Biophysics
Molecular Medicine
Female
0210 nano-technology
Intracellular
Subjects
Details
- ISSN :
- 15438392 and 15438384
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Molecular Pharmaceutics
- Accession number :
- edsair.doi.dedup.....d951eb8c6fe823caa14daa8ac3431b10
- Full Text :
- https://doi.org/10.1021/acs.molpharmaceut.8b00228